Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis
Carlos King Ho Wong(University of Leicester), GM Leung(Hong Kong Science and Technology Parks Corporation), Jianping Weng(University of Science and Technology of China), Eric Yuk Fai Wan(Nano and Advanced Materials Institute), Xiaowen Hu(Lanzhou University), Jerry Wong(University of Hong Kong), Sihui Luo(University of Science and Technology of China), Eric H. Y. Lau(Deakin University), Benjamin J. Cowling(University of Hong Kong), Xueying Zheng(University of Maryland, College Park), Edward C.H. Lau(Queen Mary Hospital), Yu Ding(University of Science and Technology of China), Ping Ling(University of Science and Technology of China)
Cited by 29
Related Papers
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
|The Lancet|2020|4.9k
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19
|Radiology|2020|1.5k
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
|Pharmacological Reviews|2021|1.1k